DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
Recruiting · NCT05977218 · Interventional (participants receive a specific treatment) · Lead sponsor: Linkoeping University
View the official record on ClinicalTrials.gov →Interventions studied
FoodSwitch
What this trial is about
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 18 and 75 years
- Self-reported type 2 diabetes with a duration of ≥2 years
- Regularly grocery shopping
Exclusion criteria
- No access to BankID (a digital identification system commonly used in Sweden)
- Failure to complete eligibility screening and run-in periods
Where it is running
1 location listed.
- Linköping University - Linköping, Sweden